Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30134
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MULLENS, Wilfried | - |
dc.contributor.author | MARTENS, Pieter | - |
dc.date.accessioned | 2019-12-12T10:09:30Z | - |
dc.date.available | 2019-12-12T10:09:30Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | CIRCULATION, 139(11), p. 1366-1370 | - |
dc.identifier.uri | http://hdl.handle.net/1942/30134 | - |
dc.description.sponsorship | Dr Martens is supported by a doctoral fellowship by the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek, Grant 1127917 N). Drs Martens and Mullens are researchers for the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk (LSM), Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.rights | 2019 American Heart Association, Inc. | - |
dc.subject.other | Editorials | - |
dc.subject.other | guideline | - |
dc.subject.other | heart failure | - |
dc.subject.other | heart ventricles | - |
dc.subject.other | mitral valve insufficiency | - |
dc.title | Sacubitril/ Valsartan to Reduce Secondary Mitral Regurgitation Refinement of Guideline- Directed Medical Therapy? | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1370 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 1366 | - |
dc.identifier.volume | 139 | - |
local.format.pages | 5 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Mullens, Wilfried; Martens, Pieter] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium. [Mullens, Wilfried] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Diepenbeek, Belgium. [Martens, Pieter] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium. | - |
local.publisher.place | PHILADELPHIA | - |
local.type.refereed | Refereed | - |
local.type.specified | Editorial Material | - |
dc.identifier.doi | 10.1161/CIRCULATIONAHA.118.038135 | - |
dc.identifier.isi | 000469317100003 | - |
item.contributor | MULLENS, Wilfried | - |
item.contributor | MARTENS, Pieter | - |
item.fullcitation | MULLENS, Wilfried & MARTENS, Pieter (2019) Sacubitril/ Valsartan to Reduce Secondary Mitral Regurgitation Refinement of Guideline- Directed Medical Therapy?. In: CIRCULATION, 139(11), p. 1366-1370. | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
crisitem.journal.issn | 0009-7322 | - |
crisitem.journal.eissn | 1524-4539 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
mullens 1.pdf | Published version | 1.1 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.